Unknown

Dataset Information

0

Sodium Channel SCN3A (NaV1.3) Regulation of Human Cerebral Cortical Folding and Oral Motor Development.

ABSTRACT: Channelopathies are disorders caused by abnormal ion channel function in differentiated excitable tissues. We discovered a unique neurodevelopmental channelopathy resulting from pathogenic variants in SCN3A, a gene encoding the voltage-gated sodium channel NaV1.3. Pathogenic NaV1.3 channels showed altered biophysical properties including increased persistent current. Remarkably, affected individuals showed disrupted folding (polymicrogyria) of the perisylvian cortex of the brain but did not typically exhibit epilepsy; they presented with prominent speech and oral motor dysfunction, implicating SCN3A in prenatal development of human cortical language areas. The development of this disorder parallels SCN3A expression, which we observed to be highest early in fetal cortical development in progenitor cells of the outer subventricular zone and cortical plate neurons and decreased postnatally, when SCN1A (NaV1.1) expression increased. Disrupted cerebral cortical folding and neuronal migration were recapitulated in ferrets expressing the mutant channel, underscoring the unexpected role of SCN3A in progenitor cells and migrating neurons.

SUBMITTER: Smith RS 

PROVIDER: S-EPMC6226006 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Channelopathies are disorders caused by abnormal ion channel function in differentiated excitable tissues. We discovered a unique neurodevelopmental channelopathy resulting from pathogenic variants in SCN3A, a gene encoding the voltage-gated sodium channel Na<sub>V</sub>1.3. Pathogenic Na<sub>V</sub>1.3 channels showed altered biophysical properties including increased persistent current. Remarkably, affected individuals showed disrupted folding (polymicrogyria) of the perisylvian cortex of the  ...[more]

Similar Datasets

Unknown Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy.
| S-EPMC2423278 | biostudies-literature
Unknown Cryo-EM structure of human voltage-gated sodium channel Na<sub>v</sub>1.6.
| S-EPMC9945969 | biostudies-literature
Unknown The voltage-gated sodium channel Na<sub>v</sub>1.7 associated with endometrial cancer.
| S-EPMC6775510 | biostudies-literature
Unknown Uncoupling sodium channel dimers restores the phenotype of a pain-linked Na<sub>v</sub> 1.7 channel mutation.
| S-EPMC7484505 | biostudies-literature
Unknown Development of high-affinity nanobodies specific for Na<sub>V</sub>1.4 and Na<sub>V</sub>1.5 voltage-gated sodium channel isoforms.
| S-EPMC8935509 | biostudies-literature
Unknown µ-Conotoxins Targeting the Human Voltage-Gated Sodium Channel Subtype Na<sub>V</sub>1.7.
| S-EPMC9506549 | biostudies-literature
Unknown Paradoxical hyperexcitability from Na<sub>V</sub>1.2 sodium channel loss in neocortical pyramidal cells.
| S-EPMC8719649 | biostudies-literature
Unknown Molecular dissection of multiphase inactivation of the bacterial sodium channel Na<sub>V</sub>Ab.
| S-EPMC6363407 | biostudies-literature
Unknown Deletion of the voltage-gated calcium channel, Ca<sub>V</sub> 1.3, causes deficits in motor performance and associative learning.
| S-EPMC9744532 | biostudies-literature
Unknown Differential binding of tetrodotoxin and its derivatives to voltage-sensitive sodium channel subtypes (Na<sub>v</sub> 1.1 to Na<sub>v</sub> 1.7).
| S-EPMC5647187 | biostudies-literature